Neurana Pharmaceuticals, Inc. — Form D/A
Neurana Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2020-02-26. The offering totals $64.9M, of which $41.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-26
- Form: D/A
- Accession: 0001567619-20-004858
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $64.9M
- Amount sold: $41.9M
- Remaining: $23.0M
- Investors: 14
- Date of first sale: 2018-05-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-312331
Issuer
- Name: Neurana Pharmaceuticals, Inc.
- CIK: 0001699458
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, 92122
- Phone: (858) 732-0702
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Brian F Dorsey | Director | San Diego, CA |
| David F Hale | Director | San Diego, CA |
| David F Kabakoff | Director | San Diego, CA |
| Joshua F Richardson | Director | San Diego, CA |
| Craig F Thompson | Director | San Diego, CA |
| Alex F Zisson | Director | San Diego, CA |
| Randall D Kaye, M.D. | Executive Officer | San Diego, CA |
| KATHLEEN D SCOTT | Executive Officer | SAN DIEGO, CA |
| Craig F Thompson | Executive Officer | San Diego, CA |
| Judy Caron | Executive Officer | San Diego, CA |
| Daniel F Becker | Director | San Diego, CA |
| Jeffrey Raser | Director | San Diego, CA |
| Jeffrey Raser | Executive Officer | San Diego, CA |
| David F Hale | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More